Harro Höfliger specializes in the development of customer-oriented process and production solutions for pharmaceutical and medical applications as well as market-oriented consumer products. In addition to innovative machine platforms and packaging machines, customized turnkey system solutions for product assembly, processing of web materials, as well as dosing and inhalation technology are the company’s core expertise.
The systematically structured portfolio of upscalable test machines and modules, as well as requirement-oriented technology platforms, results from many years of experience and targeted research and development. Thus, Harro Höfliger covers all phases from the laboratory stage to high-performance production. Visit Website
Our scientists provide development support for a wide range of pharmaceutical dosage forms with specialist expertise in OINDP development with integrated formulation and testing services for both small molecules and biologics. Our teams carry out early-stage pre-formulation support, solubility screening, drug-excipient compatibility, stability testing, and device selection support. For inhaled biologic development, comprehensive protein characterisation services supported by forced degradation and stability monitoring for the protein’s structure and bioactivity throughout formulation and storage can also be provided. Interaction with the device and closure systems are evaluated through comprehensive extractable and leachable testing and toxicological assessments.
With 30 years of experience in supporting our clients’ inhaled and nasal product developments, we deliver world-class support to help you meet the challenges of your demanding development programs. The Intertek Melbourn laboratory is inspected and approved by the UK Medicines & Healthcare Products Regulatory Agency (MHRA) for GMP compliance. The Laboratory has also been inspected by the US Food and Drug Administration (FDA) against GMP as part of clients’ pre-approval inspections. Visit Website
MUNIT is a company that specializes in the micronization of various types of pharmaceutical ingredients and compounds such as active pharmaceutical ingredients (APIs), high potent APIs, cytotoxic and cytostatic compounds, inhalation products, steroids, R&D compounds, and generics. The company is a combination of two affiliates, Jetpharma SA in Switzerland and Microchem Srl in Italy, with over 40 years of experience in the micronization sector.
MUNIT offers a range of services, including Jet, Pin, and Hammer milling, Cryogenic Micronization, Co-micronization, Sieving, Blending, De-Lumping, Technical trials, DoE Studies, Process development, and validation, QbD, and PSD analysis. MUNIT is your access point to Jetpharma’s and Microchem’s services, providing technical and commercial expertise in the micronization industry. Visit Website
Yirdoc is a leading provider of customized mesh nebulizers for inhalation delivery needs. We focus on developing formulation-specific solutions and our mesh technology and digital platform are designed to improve clinical results and formulation development. As a trusted partner to pharmaceutical and biopharmaceutical companies, Yirdoc currently works with both small molecules and biologics to provide cost-effective solutions. Whether you’re looking to improve inhalation delivery or optimize inhalation clinical outcomes, Yirdoc has the expertise and technology to help you succeed. Visit Website
Catalent Inhalation has the capabilities, expertise and state-of-the-art facilities to expedite product development, from concept and feasibility studies through commercial manufacture and release testing. With over 30 years of inhalation product experience, Catalent can handle the most complex projects and help bring your therapy to market, faster. Whether a single service or a comprehensive development package is required, Catalent offers end-to-end expertise across dose forms:
Catalent also provides comprehensive analytical, particle size engineering and clinical trial supply services. Visit Website
INKE is a developer and manufacturer of the highest quality active pharmaceutical ingredients (APIs) with complex synthesis processes, mainly for use in respiratory therapies. Visit Website
5-6 November, 2025 | San Francisco, California, USA
© 2017 Copyright All Rights Reserved | Powered by EPM Group